2 ASX shares that this top fund manager rates as a buy

BWX is one of the ASX shares that WAM Research rates as a buy in its portfolio

| More on:
Man presses green buy button and red sell button on a graph.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • WAM has outlined two ASX shares that it owns and has confidence in
  • One pick is debt collector is Credit Corp which continues to grow profitability, with growth in the US
  • Natural beauty business BWX has a growing portfolio of brands which are seeing growth

Leading fund manager Wilson Asset Management (WAM) has revealed two ASX shares that it rates as buys within the WAM Research Limited (ASX: WAX) portfolio.

WAM operates several listed investment companies (LICs). Two of those LICs are WAM Capital Limited (ASX: WAM) and WAM Leaders Ltd (ASX: WLE).

One of the LICs is called WAM Research, which looks at smaller businesses on the ASX.

WAM describes WAM Research as a LIC that invests in the most compelling undervalued growth opportunities in the Australian market.

The WAM Research portfolio has delivered gross returns (that's before fees, expenses, and taxes) of 15.4% per annum since the strategy changed in July 2010, which is superior to the All Ordinaries Total Accumulation Index (ASX: XAOA) return of 8.9% per annum.

These are the two ASX shares that WAM outlined in its most recent monthly update:

Credit Corp Group Limited (ASX: CCP)

Credit Corp was described as a business that provides debt purchase and collection, and consumer lending services in Australia, New Zealand and the US.

The Credit Corp share price outperformed during January 2022 in the lead-up to the FY22 interim result, which was released at the start of February.

WAM said that investor expectations were growing ahead of a positive result. That result delivered, according to the fund manager. There was an 8% increase in the underlying net profit after tax (NPAT) in the half-year report thanks to strong collections activity.

The period included record investment driven by the US purchased debt ledger (PDL) acquisitions alongside the acquisition of Radio Rentals in Australia.

Credit Corp's consumer lending demand accelerated to record levels over the three months to 31 December 2021. Key markets emerged from COVID lockdowns whilst pilot projects continued to demonstrate "promising results".

WAM liked the confidence that the ASX share's management showed by increasing the FY22 guidance, with PDL investment increasing to a range of between $300 million to $320 million and net profit between $92 million to $97 million.

The fund manager believes there is still upside to the given guidance and remains positive on the medium-term outlook as unsecured credit balances are "set to accelerate" as consumer stimulus fades and the impacts of COVID eases.

The above-mentioned impacts are expected to underpin organic growth, while a strong balance sheet positions the company to capitalise on further acquisitions that would add to earnings with a range of opportunities currently in the market.

BWX Ltd (ASX: BWX)

WAM describes BWX as an Australian-based company that is engaged in developing, manufacturing and marketing beauty and personal care products.

The company's expansion into the US and UK is gaining traction. When coupled with new products and a larger distribution network, this is driving growth of the market share.

It was announced in January 2022 that CEO Dave Fenlon had resigned. Mr Fenlon is going to change to be a non-executive director position on the BWX board.

WAM wasn't too concerned because the appointment of his successor is Rory Gration. Mr Gration was the chief operating officer. This demonstrated the continuity of the ASX share's management team.

BWX recently expanded its portfolio with the acquisition of a 50.1% majority stake of Go-To Skincare for $89 million. In FY21, this business generated $36.8 million of revenue and $11.6 million of earnings before interest, tax, depreciation and amortisation (EBITDA).

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended BWX Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Opinions

Businessman using a digital tablet with a graphical chart, symbolising the stock market.
Opinions

2 ASX shares I have been buying in 2024!

I’m a believer in the long-term outlook of these stocks.

Read more »

a young boy dressed up in a business suit and tie has a cute grin and holds two fingers up.
Opinions

2 of my top ASX 200 shares to consider buying before April

I would happily exchange dollars for these two shares right now.

Read more »

Father in the ocean with his daughters, symbolising passive income.
Dividend Investing

I'd spend $8k on these ASX 200 shares today to target a $6,102 annual passive income

I believe these ASX 200 shares will continue rewarding passive income investors for years to come.

Read more »

Happy woman looking for groceries. as she watches the Coles share price and Woolworths share price on her phone
Opinions

Why I bought this ASX 200 stock instead of Woolworths

I decided to put this stock in my shopping basket over Woolies.

Read more »

A happy construction worker or miner holds a fistfull of Australian money, indicating a dividends windfall
Dividend Investing

Invest $12,000 in Woodside stock and get $5,700 in passive income

Reliable dividend shares are everywhere on the ASX. Here's how you could use that to your advantage.

Read more »

Doctor doing a telemedicine using laptop at a medical clinic
Cheap Shares

1 secretly cheap ASX 200 stock I'm buying for the long run

The best performer on the index last year has had a poor start to 2024. Let's examine whether this is…

Read more »

ventilator mask
Opinions

Here's why I think the Resmed share price should be 18% higher

Just because a company's share price has gone up doesn't mean it's no longer good value.

Read more »

A male investor sits at his desk looking at his laptop screen holding his hand to his chin pondering whether to buy Macquarie shares
Index investing

3 top ASX index funds to buy now

I think these index funds are well worth a look right now.

Read more »